Wall Street Journal -
2 Oct 2020 17:00
Legions of investors piled into Moderna Inc. this year, drawn by its position as a front-runner in the global hunt for a coronavirus vaccine. Hedge-fund manager Patrick Degorce has been a believer for nearly a decade.
Share this Article
Comment on this Article
Please to comment